Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Centre Of Oncology And Immunology Limited has 1 pending office action in Biotechnology & Pharmaceuticals. The profile lists 1 distinct examiner and 1 distinct art unit. BORGEEST, CHRISTINA M is the busiest examiner, with 1 pending matter. The figures show a focused examination path for the company’s oncology and immunology-related subject matter.
The next response should address the examiner’s particular grounds and explain the technical distinctions that support the claims. Counsel should verify that each proposed amendment is grounded in the application disclosure and remains aligned with the intended therapeutic scope. With one examiner and one art unit represented, the file can be managed through a unified claim strategy and a consistent technical record.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BORGEEST, CHRISTINA M | 1 | 55.7% | +21.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18176819 | CAS9 PROTEIN FOR GENOME EDITING | BORGEEST, CHRISTINA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18176819 | CAS9 PROTEIN FOR GENOME EDITING | BORGEEST, CHRISTINA M | — |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18176819 | CAS9 PROTEIN FOR GENOME EDITING | BORGEEST, CHRISTINA M | 1675 | §102§103§112 | Non-Final OA | — | Pending | Mar 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCentre Of Oncology And Immunology Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Christina M Borgeest has the most, with 1 of Centre Of Oncology And Immunology Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
